This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Mary Ann Tran: Innovator in Pharmaceutical Combinations
Introduction
Mary Ann Tran is a notable inventor based in Somerville, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug combinations. Her work is characterized by a commitment to improving therapeutic outcomes for patients.
Latest Patents
Mary Ann Tran holds a patent for a pharmaceutical combination that involves the co-administration of taxane and a specific compound known as N-(1-cyclohexyl-2-{2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide or its pharmaceutically acceptable salts. This invention aims to enhance the efficacy of cancer treatments by optimizing drug delivery and effectiveness.
Career Highlights
Mary Ann Tran is currently associated with Novartis AG, a leading global healthcare company. Her role at Novartis allows her to collaborate with other experts in the field and contribute to groundbreaking research and development in pharmaceuticals.
Collaborations
Throughout her career, Mary Ann has worked alongside talented colleagues, including Michael Rugaard Jensen and Christopher Sean Straub. These collaborations have fostered an environment of innovation and have led to advancements in pharmaceutical science.
Conclusion
Mary Ann Tran's contributions to the pharmaceutical industry exemplify her dedication to innovation and improving patient care. Her patent and work at Novartis AG highlight her role as a key player in the development of effective drug combinations.